DrugPatentWatch Database Preview
Eugia Pharma Company Profile
Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic and branded alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has twenty-two approved drugs.
There are two tentative approvals on EUGIA PHARMA drugs.
Summary for Eugia Pharma
| US Patents: | 0 |
| Tradenames: | 19 |
| Ingredients: | 19 |
| NDAs: | 22 |
| Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | CAPECITABINE | capecitabine | TABLET;ORAL | 210604-002 | Apr 17, 2018 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Eugia Pharma | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 212773-002 | Jul 23, 2020 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Eugia Pharma | ANASTROZOLE | anastrozole | TABLET;ORAL | 212434-001 | Jul 24, 2020 | AB | RX | No | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
